SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Conference on August 10th at 10:55 a.m. ET. The event can be accessed via a live webcast on the company’s website, with a replay available afterward. SpringWorks focuses on developing life-changing medicines for severe rare diseases and cancer, boasting a targeted oncology pipeline that includes late-stage clinical trials for rare tumors and genetically defined cancers. For more details, visit SpringWorks’ website.
- None.
- None.
STAMFORD, Conn., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Conference on Wednesday, August 10th at 10:55 a.m. ET.
To access the live webcast please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference.
About SpringWorks Therapeutics
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two potentially registrational clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients with cancer. For more information, visit www.springworkstx.com and follow @SpringWorksTx on Twitter and LinkedIn.
Contacts:
Kim Diamond
Vice President, Communications and Investor Relations
Phone: 203-561-1646
Email: kdiamond@springworkstx.com
Samantha Hilson Sandler
Director, Investor Relations
Phone: 203-461-5501
Email: samantha.sandler@springworkstx.com
FAQ
What is the date and time of SpringWorks Therapeutics' participation in the Wedbush PacGrow Healthcare Conference?
How can I access the webcast for SpringWorks Therapeutics' conference participation?
What is the focus of SpringWorks Therapeutics as a company?
What is the Nasdaq ticker symbol for SpringWorks Therapeutics?
Are there any clinical trials mentioned by SpringWorks Therapeutics?
